Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice

H. Mark Kenney1, Ronald W. Wood1, G. Ramı́rez1, Richard D. Bell2, Kiana L. Chen1, Lindsay Schnur1, Homaira Rahimi1, Benjamin Korman1, Lianping Xing1, Christopher T. Ritchlin1, Edward M. Schwarz3, Calvin Cole1
1Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA
2Department of Research, Hospital for Special Surgery, New York, NY, USA
3Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA

Tóm tắt

Abstract Background Although treatment options and algorithms for rheumatoid arthritis (RA) have improved remarkably in recent decades, there continues to be no definitive cure or pharmacologic intervention with reliable long-term efficacy. For this reason, the combination of medications and healthy lifestyle modifications are essential for controlling joint disease, and extra-articular manifestations of RA, such as interstitial lung disease (ILD) and other lung pathologies, which greatly impact morbidity and mortality. Generally, exercise has been deemed beneficial in RA patients, and both patients and clinicians are motivated to incorporate effective non-pharmacologic interventions. However, there are limited evidence-based and specific exercise regimens available to support engagement in such activities for RA patients. Here, we provided the continuous opportunity for exercise to mice and implemented automated recording and quantification of wheel running behavior. This allowed us to describe the associated effects on the progression of inflammatory-erosive arthritis and ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. Methods Wild-type (WT; males, n=9; females, n=9) and TNF-Tg (males, n=12; females, n=14) mice were singly housed with free access to a running wheel starting at 2 months until 5 to 5.5 months of age. Measures of running included distance, rate, length, and number of run bouts, which were derived from continuously recorded data streams collected automatically and in real-time. In vivo lung, ankle, and knee micro-computed tomography (micro-CT), along with terminal micro-CT and histology were performed to examine the association of running behaviors and disease progression relative to sedentary controls. Results TNF-Tg males and females exhibited significantly reduced running distance, rate, length, and number of run bouts compared to WT counterparts by 5 months of age (p<0.0001). Compared to sedentary controls, running males and females showed increased aerated lung volumes (p<0.05) that were positively correlated with running distance and rate in female mice (WT: Distance, ρ=0.705/rate, ρ=0.693 (p<0.01); TNF-Tg: ρ=0.380 (p=0.06)/ρ=0.403 (p<0.05)). Talus bone volumes were significantly reduced in running versus sedentary males and negatively correlated with running distance and rate in TNF-Tg mice (male: ρ=−903/ρ=−0.865; female: ρ=−0.614/ρ=−0.594 (p<0.001)). Histopathology validated the lung and ankle micro-CT findings. Conclusions Implementation of automated wheel running behavior metrics allows for evaluation of longitudinal activity modifications hands-off and in real-time to relate with biomarkers of disease severity. Through such analysis, we determined that wheel running activity increases aerated lung volumes, but exacerbates inflammatory-erosive arthritis in TNF-Tg mice. To the end of a clinically relevant model, additional functional assessment of these outcomes and studies of pain behavior are warranted.

Từ khóa


Tài liệu tham khảo

Firestein G. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–61.

Gabriel S, Crowson C, Kremers H, Doran M, Turesson C, O'Fallon W, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48(1):54–8.

Minaur N, Jakoby R, Cosh J, Taylor G, Rasker J. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl. 2004;69:3–8.

Kuo C, Luo S, See L, Chou I, Chang H, Yu K. Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int. 2013;33(2):355–60.

Bongartz T, Nannini C, Medina-Velasquez Y, Achenbach S, Crowson C, Ryu J, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583–91.

Olson A, Swigris J, Sprunger D, Fischer A, Fernandez-Perez E, Solomon J, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372–8.

Keystone E, Smolen J, Van Riel P. Developing an effective treatment algorithm for rheumatoid arthritis. Rheumatology (Oxford). 2012;51:v48–54.

Smolen J, Landewé R, Bijlsma J, Burmester G, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99.

Cooney J, Law R, Matschke V, Lemmey A, Moore J, Ahmad Y, et al. Benefits of Exercise in Rheumatoid Arthritis. J Aging Res. 2011;2011:681640.

Van Den Ende C, Hazes J, Le Cessie S, Mulder W, Belfor D, Breedveld F, et al. Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial. Ann Rheum Dis. 1996;55(11):798–805.

Ytterberg S, Mahowald M, Krug H. Exercise for arthritis. Bailliere's Clin Rheumatol. 1994;8(1):161–89.

De Jong Z, Munneke M, Zwinderman A, Kroon H, Jansen A, Ronday K, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum. 2003;48(9):2415–24.

Brand D, Latham K, Rosloniec E. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269–75.

Inglis J, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, et al. Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther. 2007;9(5):R113.

Kontoyiannis D, Pasparakis M, Pizarro T, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999;10(3):387–98.

Caplazi P, Baca M, Barck K, Carano R, DeVoss J, Lee W, et al. Mouse Models of Rheumatoid Arthritis. Vet Pathol. 2015;52(5):819–26.

Cambre I, Gaublomme D, Burssens A, Jacques P, Schryvers N, Myunck A, et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat Commun. 2018;9:4613.

Tepper J, Weiss B, Cox C. Microanalysis of ozone depression of motor activity. Toxicol Appl Pharmacol. 1982;64(2):317–26.

Li P, Schwarz E. The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol. 2003;25(1):19–33.

Wu E, Henkes Z, McGowan B, Bell R, Velez M, Livingstone A, et al. TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21 +/CD23 - B Cell Follicles Is Prevented With Anti-TNF Therapy. J Immunol. 2019;203(11):2837–49.

Xiong L, Xiong L, Ye H, Ma W. Animal models of rheumatoid arthritis-associated interstitial lung disease. Immun Inflamm Dis. 2021;9(1):37–47.

Crowson C, Matteson E, Myasoedova E, Michet C, Ernste F, Warrington K, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63(3):633–9.

Bell R, Wu E, Rudmann C, Forney M, Kaiser C, Wood R, et al. Selective sexual dimorphisms in musculoskeletal and cardiopulmonary pathologic manifestations and mortality incidence in the tumor necrosis factor-transgenic mouse model of rheumatoid arthritis. Arthritis Rheum. 2019;71(9):1512–23.

Bouta E, Kuzin I, De Mesy BK, Wood R, Rahimi H, Ji R, et al. Brief report: treatment of tumor necrosis factor-transgenic mice with anti-tumor necrosis factor restores lymphatic contractions, repairs lymphatic vessels, and may increase monocyte/macrophage egress. Arthritis Rheum. 2017;69(6):1187–93.

Kenney H, Peng Y, Bell R, Wood R, Xing L, Ritchlin C, et al. Persistent popliteal lymphatic muscle cell coverage defects despite amelioration of arthritis and recovery of popliteal lymphatic vessel function in TNF-Tg mice following anti-TNF therapy. Sci Rep. 2022;12:12751.

Douni E, Akassoglou K, Alexopoulou L, Georgopoulos S, Haralambous S, Hill S, et al. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm 1995. 1996;47(1-2):27–36.

Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991;10(13):4025–31.

Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N, et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 2002;21(16):4307–16.

Tepper J, Weiss B. Determinants of behavioral response with ozone exposure. J Appl Physiol (1985). 1986;60(3):868–75.

Bell R, Rudmann C, Wood R, Schwarz E, Rahimi H. Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice. PLoS One. 2018;13(1):e0190678.

Proulx S, Kwok E, You Z, Papuga M, Beck C, Shealy D, et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum. 2007;56(12):4024–37.

Kenney H, Peng Y, Chen K, Ajalik R, Schnur L, Wood R, et al. A High-Throughput Semi-Automated Bone Segmentation Workflow for Murine Hindpaw Micro-CT Datasets. Bone Rep. 2022;16:101167.

Bouxsein M, Boyd S, Christiansen B, Guldberg R, Jepsen K, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468–86.

Li J, Ju Y, Bouta E, Xing L, Wood R, Kuzin I, et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum. 2013;65(1):130–8.

Li J, Kuzin I, Moshkani S, Proulx S, Xing L, Skrombolas D, et al. Expanded CD23(+)/CD21(hi) B Cells in Inflamed Lymph Nodes Are Associated With the Onset of Inflammatory-Erosive Arthritis in TNF-transgenic Mice and Are Targets of anti-CD20 Therapy. J Immunol. 2010;184(11):6142–50.

Li J, Zhou Q, Wood R, Kuzin I, Bottaro A, Ritchlin C, et al. CD23+/CD21hi B cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice. Arthritis Res Ther. 2011;13(4):R138.

Wu E, Eliseeva S, Rahimi H, Schwarz E, Georas S. Restrictive lung disease in TNF-transgenic mice: correlation of pulmonary function testing and micro-CT imaging. Exp Lung Res. 2019;45(7):175–87.

Bell R, Whie R, Garcia-Hernandez M, Wu E, Rahimi H, Marangoni R, et al. Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Arthritis Rheum. 2020;72(10):1759–70.

Yi X, Liu X, Kenney H, Duan R, Lin X, Schwarz E, et al. TNF-polarized macrophages produce insulin like 6 peptide to stimulate bone formation in rheumatoid arthritis in mice. J Bone Miner Res. 2021;36(12):2426–39.

Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum. 2005;52(11):3448–59.

Guo Q, Wang Y, Xu D, Nossent J, Pavlos N, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.

Cabral A, Loya B, Alarcon-Segovia D. Bone remodeling and osteophyte formation after remission of rheumatoid arthritis. J Rheumatol. 1989;16(11):1421–7.

Figueiredo C, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, et al. Quantification and Impact of Secondary Osteoarthritis in Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(9):2114–21.

Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009;11(1):R7.

Forslind K, Hafstrom I, Ahlmen M. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis. 2007;66(1):46–52.

Tengstrand B, Ahlmen M, Hafstrom I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol. 2004;31(2):214–22.

Da Silva J, Hall G. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol. 1992;6(1):196–219.

Lee H, Kim D, Yoo B, Seo J, Rho J, Colby T, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019–27.

Wu E, Ambrosini R, Kottmann R, Ritchlin C, Schwarz E, Rahimi H. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology. Curr Rheumatol Rev. 2019;15(4):277–89.

Lakes E, Allen K. Gait analysis methods for rodent models of arthritic disorders: reviews and recommendations. Osteoarthr Cartil. 2016;24(11):1837–49.

Jacobs B, Allen K. Exercise effects on gait in a rodent model of osteoarthritis. Osteoarthr Cartil. 2018;26:S373.

Li J, Yi X, Yao Z, Xing L, Boyce B, Chakkalakal J. TNF receptor-associated factor 6 mediates TNFα-induced skeletal muscle atrophy in mice during aging. J Bone Miner Res. 2020;35(8):1535–48.

Greiwe J, Cheng B, Rubin D, Yarasheski K, Semenkovich C. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001;15(2):475–82.

Chhetri J, De Souto BP, Fougere B, Rolland Y, Vellas B, Cesari M. Chronic inflammation and sarcopenia: A regenerative cell therapy perspective. Exp Gerontol. 2018;103:115–23.

Alliston T, Hernandez C, Findlay D, Felson D, Kennedy O. Bone Marrow Lesions in Osteoarthritis: What Lies Beneath. J Orthop Res. 2018;36(7):1818–25.

Yusuf E, Kortekaas M, Watt I, Huizinga T, Kloppenburg M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review Ann Rheum Dis. 2011;70(1):60–7.

Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, et al. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum. 2011;63(3):691–9.

Law R, Breslin A, Oliver E, Mawn L, Markland D, Maddison P, et al. Perceptions of the effects of exercise on joint health in rheumatoid arthritis patients. Rheumatology (Oxford). 2010;49(12):2444–51.